Shenglong Li
发表
A rapid and e cient screening system for neutralizing antibodies and its application for SARS- CoV-2
Weiqi Wang,
Jie-Li Hu,
Yang Wu,
2021
.
D. Qu,
Jie-Li Hu,
S. Mu,
2020,
Frontiers in Immunology.
D. Qu,
Jie-Li Hu,
A. Huang,
2021
.
Kai,
Wang,
Jie-Li Hu,
2020
.
Ziqi Yue,
Kaiqi Yang,
Shenglong Li,
2022,
Frontiers in Immunology.
Xiuzhen Zhang,
Qiling Peng,
Jianwei Wang,
2022,
Viral immunology.
Yi Wang,
A. Jin,
Tingting Li,
2022,
Frontiers in Medicine.
Chen Qian,
S. Mu,
A. Jin,
2021,
Frontiers in Immunology.
Jianwei Wang,
D. Pang,
A. Jin,
2020,
bioRxiv.
E. Burstein,
X. Mo,
Lu Chen,
2023,
Signal Transduction and Targeted Therapy.
A. Jin,
Meiying Shen,
Jingjing Huang,
2021,
Frontiers in Cell and Developmental Biology.
Jianwei Wang,
A. Jin,
Tingting Li,
2020,
Genes & Diseases.
D. Qu,
Jie-Li Hu,
S. Mu,
2021,
Nature Communications.
Liaobin Chen,
Biao Chen,
Qing Yang,
2022,
Stem cells international.
Jie-Li Hu,
S. Mu,
Yang Wu,
2020,
bioRxiv.
Gaofu Zhang,
Shenglong Li,
Yun-Ying Wang,
2014,
Drug Research.
p38 inhibition enhances TCR-T cell function and antagonizes the immunosuppressive activity of TGF-β.
D. Pang,
A. Jin,
Kun Tao,
2021,
International immunopharmacology.